Judy Kim, MD
Retina Specialist · Dallas, TXNPI 1992756746
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $204,506 of the $255,720 with a category attached, or 80.0%. It is spread thinly across 25 manufacturers, the largest accounting for just 11.6%. Among retina specialist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 195 payments — averaging $1311.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Apellis Pharmaceuticals, Inc.$30K
- Novartis$27K
- Alcon$27K
- Genentech USA, Inc.$26K
- Genentech, Inc.$24K
- Regeneron$22K
- plus $101K from 19 others
Across 17 payments — averaging $1261.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$18K
- Regeneron$2K
- Genentech, Inc.$1K
What the payments were for
- Consulting fees$204,50680%
- Speaking & faculty fees$27,81411%
- Travel & lodging$16,9437%
- Food & beverage$6,4383%
- Gifts$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Apellis Pharmaceuticals, Inc. | 20 | $29,577 |
| Novartis | 9 | $27,394 |
| Alcon | 21 | $26,866 |
| Genentech USA, Inc. | 24 | $25,568 |
| Genentech, Inc. | 19 | $23,674 |
| Regeneron | 22 | $21,989 |
| AbbVie(2 entities) | 24 | $16,885 |
| Dutch Ophthalmic, USA | 6 | $15,276 |
| Bausch & Lomb Americas Inc. | 7 | $11,861 |
| F. Hoffmann-la Roche AG | 3 | $9,110 |
| Regeneron Healthcare Solutions, Inc. | 6 | $8,446 |
| Coopervision Inc. | 3 | $6,000 |
| Harrow Eye, LLC | 2 | $5,600 |
| Coherus Oncology, Inc. | 5 | $5,330 |
| Amgen | 2 | $4,915 |
| Eyepoint US, Inc. | 6 | $4,796 |
| Optos, Inc. | 2 | $4,000 |
| Beaver-visitec International, Inc. | 2 | $2,100 |
| Samsung Bioepis Co., Ltd. | 1 | $2,000 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $1,793 |
| AstraZeneca | 1 | $1,235 |
| Novartis Pharma AG | 2 | $1,104 |
| Alimera Sciences, Inc. | 3 | $111 |
| Carl Zeiss Meditec, Inc. | 1 | $70 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BEOVU$27,394
- Syfovre$19,156
- EYLEA$17,614
- Unity$15,988
- EVA, combined machine$12,859
- EYLEA HD$12,416
- VABYSMO$12,198
- Constellation$11,988
- SUSVIMO$11,378
- NGENUITY$10,045
- Alcon Greishaber Finesse$9,434
- Luxor$9,100
- Lucentis$9,075
- XOLAIR$8,292
- Avastin$8,220
- TECENTRIQ$8,220
- MiSight Contact Lens$6,000
- TRIESENCE$5,600
- Cimerli$5,280
- PAVBLU$4,915
How this compares
$255,720 in reported general payments places this provider in the 95th percentile of 108 retina specialist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Dallas
- Gregory KozielecDallas$4K
- Noy AshkenazyDallas$3K
- Courtney CrawfordBurleson$342K
- Jeremiah BrownSchertz$339K
- Victor GonzalezMcAllen$335K
- Emmanuel ChangBellaire$254K
- Ting Fang SuarezBellaire$156K
- Hemang PandyaPlano$153K
- Margaret RunnerSouthlake$71K
- Moises ChicaSan Antonio$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.